MA
Mottiwala Aziz
Directeur Commercial
OtherM
Insider track record
ExecutiveNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Mottiwala Aziz, Directeur Commercial. Director active across 1 company, notably Tarsus Pharmaceuticals, Inc.. Aggregated, 18 reports have been recorded. Breakdown: 0 buy · 12 sells. Total volume traded: €1.5m. History available since 10 September 2021. The latest transaction was disclosed on 17 March 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Mottiwala Aziz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
4,286 shares@ US$69.4216.6% of flowCommon StockSEC:0001788542-26-000007:0
26,482 sharesCommon StockSEC:0001788542-26-000005:0
17,500 shares@ US$43.7651.7% of flowCommon StockSEC:0001819790-25-000081:0
3,643 shares@ US$46.2918.4% of flowCommon StockSEC:0001819790-25-000059:0
20,957 sharesCommon StockSEC:0001819790-25-000042:0
12,938 sharesCommon StockSEC:0001819790-24-000047:0
2,400 shares@ US$20.055.1% of flowCommon StockSEC:0001788542-23-000006:0
100 shares@ US$20.000.2% of flowCommon StockSEC:0001209191-23-036395:0
2,143 shares@ US$18.614.4% of flowCommon StockSEC:0001209191-23-035579:0
349 shares@ US$12.890.5% of flowCommon StockSEC:0001788542-23-000004:0
339 shares@ US$13.280.5% of flowCommon StockSEC:0001788542-23-000002:0
4,790 sharesCommon StockSEC:0001209191-23-019879:0
6,857 shares@ US$17.7214.0% of flowCommon StockSEC:0001788542-22-000006:0
4,416 shares@ US$10.995.8% of flowCommon StockSEC:0001788542-22-000004:0
1,889 shares@ US$28.113.0% of flowCommon StockSEC:0001819790-21-000055:0
100 shares@ US$28.030.2% of flowCommon StockSEC:0001819790-21-000047:0
5,458 shares@ US$26.7538.1% of flowCommon StockSEC:0001819790-21-000045:0
4,350 shares@ US$10.992.6% of flowCommon StockSEC:0001819790-21-000031:0
About Mottiwala Aziz
Mottiwala Aziz is Chief Commercial Officer at Tarsus Pharmaceuticals, Inc. The 18 filings in the recent sample available, from 2021-09-14 to 2026-03-19, are all associated with sales totaling EUR 1465737, with the modal transaction nature shown as sale.